Dr. Demas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Salem Regional Medical Center Radiation Oncology
2020 E State St Ste A
Salem, OH 44460Phone+1 330-332-7360Fax+1 330-332-7359
Summary
- Dr. William Demas is a radiation oncologist in Salem, OH and is affiliated with multiple hospitals in the area, including Summa Health System, Cleveland Clinic, Medina Hospital, Alliance Community Hospital, Salem Regional Medical Center, Summa Barberton Citizens Hospital, Wooster Community Hospital, and Cleveland Clinic Akron General. He received his medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 36 years. He is experienced in stereotactic radiosurgery, intensity-modulated radiation therapy, radiosurgery, head and neck radiation oncology, and stereotactic body radiotherapy.
Education & Training
- University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 1985 - 1986
- Maimonides Medical Center/SUNY Downstate HSUResidency, Radiation Oncology, 1981 - 1985
- State University of New York Downstate Medical Center College of MedicineClass of 1981
Certifications & Licensure
- CA State Medical License 1986 - 2026
- TX State Medical License 1986 - 2026
- NY State Medical License 1983 - 2025
- OH State Medical License 1986 - 2025
- American Board of Radiology Radiation Oncology
Clinical Trials
- Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2003 Jun 01
- Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Start of enrollment: 2005 Mar 01
- Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer Start of enrollment: 2005 Jul 26
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsRandomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: re...Michael J. Seider, Stephanie L. Pugh, Corey J. Langer, Gwen Wyatt, W. Demas
Annals of Nuclear Medicine. 2018-08-09 - 32 citationsMinimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.Srinivas Raman, Keyue Ding, Edward Chow, Ralph M. Meyer, Yvette M. van der Linden
Quality of Life Research. 2018-04-01 - 1 citationsGender and age make no difference in the re-irradiation of painful bone metastases: A secondary analysis of the NCIC CTG SC.20 randomized trial.Ronald Chow, Keyue Ding, Vithusha Ganesh, Ralph M. Meyer, Yvette M. van der Linden
Radiotherapy and Oncology. 2017-11-05
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: